Scinai Immunotherapeutics Ltd (SCNI) — Strategic Asset Allocation Index
Scinai Immunotherapeutics Ltd (SCNI) has a Strategic Asset Allocation Index of 1660.9% as of September 2022. Strategic assets (PP&E of $43.59 Million plus long-term investments of $-) total $43.59 Million, measured against net assets of $2.62 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Scinai Immunotherapeutics Ltd Strategic Asset Allocation Index (2002–2021)
This chart shows how Scinai Immunotherapeutics Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2002 to 2021. As of September 2022, the index stands at 1660.9%, representing strategic assets of $43.59 Million against net assets of $2.62 Million USD. Explore Scinai Immunotherapeutics Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Scinai Immunotherapeutics Ltd (2002–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Scinai Immunotherapeutics Ltd from 2002 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see SCNI stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 1445.3% | $14.19 Million | $14.19 Million | $- | $982.00K | ▲ +1444.5 pp |
| 2006 | 0.8% | $14.00K | $14.00K | $- | $1.74 Million | ▼ -0.3 pp |
| 2005 | 1.1% | $30.00K | $30.00K | $- | $2.70 Million | ▲ +0.1 pp |
| 2004 | 1.0% | $42.00K | $42.00K | $- | $4.11 Million | ▼ -5.3 pp |
| 2003 | 6.3% | $41.00K | $41.00K | $- | $648.00K | ▼ -51.5 pp |
| 2002 | 57.8% | $52.00K | $52.00K | $- | $90.00K | — |